We are proud to share that Patrick Falvey, Principal Consultant at Latham BioPharma Group (LBG), was featured in the American Pharmaceutical Review!
In his interview, published on October 1, 2024, Patrick shared his insights on the evolving global trends in biomanufacturing. The feature was published ahead of CPHI Milan, the world’s largest pharma event, where a record 62,000 attendees were expected.
As a thought leader in the field, Patrick moderated a panel at CPHI Milan, bringing together leading analysts to discuss new opportunities for CDMOs in the biologics and advanced therapies space. The session focused on the growth of this sector, the increasing presence of bio-focused CDMOs, and how outsourcing had become a critical component in drug development.
LBG congratulated Patrick on this recognition of his expertise and his contributions to advancing the biomanufacturing industry.
You may read the full article here.
